Hence then, the article about jazz pharmaceuticals and pharmamar announce results of atlantis phase 3 study evaluating zepzelca in combination with doxorubicin for patients with small cell lung cancer following one prior platinum containing line was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Jazz Pharmaceuticals and PharmaMar Announce Results of ATLANTIS Phase 3 Study Evaluating Zepzelca™ in Combination with Doxorubicin for Patients with Small Cell Lung Cancer Following One Prior Platinum-containing Line )
Also on site :
- Baystate Health doctor on probation after lewd behavior inside his office
- ‘Seekers Of Infinite Love’ Review: Hannah Einbinder and Justin Theroux Star In Smart Cult Comedy That’s Worthy Of A Cult Of Its Own – SXSW
- The U.S. Mint just dropped the olive branch from the dime. What does that mean for the country?